Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644819
Preoperative Outreach to Improve Surgical AttendanceUniversity of California, San FranciscoNot Yet RecruitingNot Applicable
NCT07644819Not Yet Recruiting
Not Applicable
Preoperative Outreach to Improve Surgical AttendanceUniversity of California,...
NCT07644455
Percutaneous Biopsy After Neoadjuvant Chemotherapy.Instituto do Cancer do Estado de São PauloNot Yet RecruitingNot Applicable
NCT07644455Not Yet Recruiting
Not Applicable
Percutaneous Biopsy After Neoadjuvant Chemotherapy.Instituto do Cancer do Es...
NCT07646275
Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy LossHarran UniversityCompletedNot Applicable
NCT07646275Completed
Not Applicable
Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy LossHarran University
NCT07643948
Impacts of HIV Treatment Regimens on Archived Drug ResistanceChinese University of Hong KongRecruiting
NCT07643948Recruiting
—
Impacts of HIV Treatment Regimens on Archived Drug ResistanceChinese University of Hon...
NCT07645534
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.Valenta Pharm JSCRecruitingPhase 1
NCT07645534Recruiting
Phase 1
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta...Valenta Pharm JSC
NCT07644650
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsMabsoft Therapeutics (Australia) Pty. Ltd.Not Yet RecruitingPhase 1
NCT07644650Not Yet Recruiting
Phase 1
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsMabsoft Therapeutics (Aus...
NCT07646548
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron PharmaceuticalsNot Yet RecruitingPhase 1
NCT07646548Not Yet Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Be...Regeneron Pharmaceuticals
NCT07645495
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07645495Not Yet Recruiting
Not Applicable
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef University
NCT07645820
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis FlaresCastle Biosciences IncorporatedRecruiting
NCT07645820Recruiting
—
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Fla...Castle Biosciences Incorp...
NCT07645547
Prophylactic Use of ciNPWT in Gynecologic LaparotomyUniversity Hospital Hradec KraloveNot Yet RecruitingNot Applicable
NCT07645547Not Yet Recruiting
Not Applicable
Prophylactic Use of ciNPWT in Gynecologic LaparotomyUniversity Hospital Hrade...
NCT07645716
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic OncologyFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07645716Not Yet Recruiting
—
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards...Fondazione Policlinico Un...
NCT07646483
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee OsteoarthritisPharmaResearch Co.,LtdNot Yet RecruitingNot Applicable
NCT07646483Not Yet Recruiting
Not Applicable
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and...PharmaResearch Co.,Ltd
NCT07644091
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer PatientsMethodist Health SystemRecruiting
NCT07644091Recruiting
—
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Pa...Methodist Health System
NCT07645248
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKlineNot Yet RecruitingPhase 3
NCT07645248Not Yet Recruiting
Phase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1...GlaxoSmithKline
NCT07645105
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of SilesiaCompleted
NCT07645105Completed
—
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or Obes...Medical University of Sil...
NCT07644559
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.RecruitingPhase 2
NCT07644559Recruiting
Phase 2
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07645638
Virtual Reality Cognitive Stimulation for Alzheimer'sUniversidad de BurgosCompletedNot Applicable
NCT07645638Completed
Not Applicable
Virtual Reality Cognitive Stimulation for Alzheimer'sUniversidad de Burgos
NCT07645339
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier RepairL'OrealActive Not RecruitingNot Applicable
NCT07645339Active Not Recruiting
Not Applicable
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier...L'Oreal
NCT07645352
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 ZimbabweFred Hutchinson Cancer CenterNot Yet RecruitingNot Applicable
NCT07645352Not Yet Recruiting
Not Applicable
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervica...Fred Hutchinson Cancer Ce...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)